These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 27004407)

  • 1. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
    Li M; Zhang Z; Hill DL; Wang H; Zhang R
    Cancer Res; 2007 Mar; 67(5):1988-96. PubMed ID: 17332326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
    Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
    Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
    Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
    Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
    Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
    PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2.
    Wang BY; Cao J; Chen JW; Liu QY
    Med Oncol; 2014 Nov; 31(11):270. PubMed ID: 25280518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL; Guo L; Wang GH
    Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
    Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
    Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells.
    Li J; Liu R; Yang Y; Huang Y; Li X; Liu R; Shen X
    Oncol Rep; 2014 May; 31(5):2181-6. PubMed ID: 24676587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.
    Li H; Li L; Mei H; Pan G; Wang X; Huang X; Wang T; Jiang Z; Zhang L; Sun L
    Cancer Biol Ther; 2020; 21(2):178-188. PubMed ID: 31663424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation.
    Xiaowen H; Yi S
    Mol Biol Rep; 2012 Sep; 39(9):8763-70. PubMed ID: 22707197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.
    Jin ZQ; Hao J; Yang X; He JH; Liang J; Yuan JW; Mao Y; Liu D; Cao R; Wu XZ; Li X; Chen D
    Oncol Rep; 2018 Oct; 40(4):2127-2136. PubMed ID: 30106443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro.
    Li M; Wang X; Liu M; Qi X; Li J
    Biomed Pharmacother; 2014 Jun; 68(5):527-35. PubMed ID: 24986326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
    Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
    Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
    Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L
    Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
    Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
    Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
    Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
    Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.